Quantamental Technologies’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$323K Buy
4,310
+967
+29% +$74.4K 0.3% 127
2023
Q2
$258K Sell
3,343
-261
-7% -$20.8K 0.11% 326
2023
Q1
$299K Buy
+3,604
New +$299K 0.16% 234
2022
Q3
Sell
-4,975
Closed -$308K 561
2022
Q2
$308K Buy
+4,975
New +$308K 0.14% 273
2021
Q2
Sell
-3,745
Closed -$242K 256
2021
Q1
$242K Buy
+3,745
New +$241K 0.78% 61
2020
Q4
Sell
-33,770
Closed -$2.13M 165
2020
Q3
$2.13M Buy
33,770
+13,447
+66% +$933K 1.58% 6
2020
Q2
$1.56M Buy
20,323
+8,255
+68% +$633K 1.04% 13
2020
Q1
$902K Buy
12,068
+6,245
+107% +$432K 2.11% 8
2019
Q4
$378K Sell
5,823
-7,677
-57% -$500K 0.19% 184
2019
Q3
$856K Sell
13,500
-1,117
-8% -$73K 0.28% 62
2019
Q2
$988K Buy
14,617
+3,777
+35% +$248K 0.36% 29
2019
Q1
$705K Buy
10,840
+7,255
+202% +$482K 0.32% 42
2018
Q4
$224K Buy
+3,585
New +$251K 0.13% 255

Other funds holding GILD

Quantamental Technologies's GILD Position: Q3 2023 in Review

Quantamental Technologies increased its Gilead Sciences (GILD) stake by 29% in Q3 2023, buying an estimated $74.4K and bringing the position to 4,310 shares worth $323K. The position accounts for 0.3% of the portfolio, ranked #127.

Quantamental Technologies first reported a position in GILD in Q4 2018 and has held it in 13 quarters since. The position peaked at $2.13M in Q3 2020. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • Quantamental Technologies held 4,310 shares of Gilead Sciences worth $323K as of Q3 2023.
  • Quantamental Technologies bought 967 Gilead Sciences shares in Q3 2023, an estimated $74.4K.
  • Gilead Sciences made up 0.3% of Quantamental Technologies's portfolio in Q3 2023, its #127 holding.
  • Quantamental Technologies first reported a position in Gilead Sciences in Q4 2018 and has held it in 13 quarters since.
  • Quantamental Technologies's Gilead Sciences position peaked at $2.13M in Q3 2020.
  • 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.